H. Wilke

Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial

H. Wilke, Kei Muro, Eric Van Cutsem et al. · The Lancet Oncology · 2014 · 2.4K citations

Surgical Oncology, Gastrointestinal Oncology, Medicine +7

Chemoradiation With and Without Surgery in Patients With Locally Advanced Squamous Cell Carcinoma of the Esophagus

M. Stahl, Martin Stuschke, Nils Lehmann et al. · Journal of Clinical Oncology · 2005 · 1.3K citations

Phase III Comparison of Preoperative Chemotherapy Compared With Chemoradiotherapy in Patients With Locally Advanced Adenocarcinoma of the Esophagogastric Junction

M. Stahl, Martin K. Walz, Martin Stuschke et al. · Journal of Clinical Oncology · 2009 · 943 citations

Final Results of a Randomized Phase III Trial of Sequential High-Dose Methotrexate, Fluorouracil, and Doxorubicin Versus Etoposide, Leucovorin, and Fluorouracil Versus Infusional Fluorouracil and Cisplatin in Advanced Gastric Cancer: A Trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group

U. Vanhoefer, Philippe Rougier, H. Wilke et al. · Journal of Clinical Oncology · 2000 · 533 citations

Implantable Vascular Access Systems: Experience in 1500 Patients with Totally Implanted Central Venous Port Systems

H.‐J. Kock, M. Pietsch, Ulla Krause et al. · World Journal of Surgery · 1998 · 385 citations